Market Analysts see Evolus Inc. [EOLS] gaining to $12. Time to buy?

Evolus Inc. [NASDAQ: EOLS] surged by $1.51 during the normal trading session on Tuesday and reaching a high of $14.50 during the day while it closed the day at $14.02. The company report on March 3, 2021 that Evolus to Participate in Two Upcoming Investor Conferences.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, announced that members of management will be participating in two upcoming virtual investor conferences.

Event:.

Evolus Inc. stock has also gained 42.19% of its value over the past 7 days. However, EOLS stock has inclined by 266.06% in the 3 months of the year. Over the past six months meanwhile, it has gained 291.62% and gained 317.26% year-on date.

The market cap for EOLS stock reached $449.34 million, with 33.75 million shares outstanding and 21.69 million shares in the current float. Compared to the average trading volume of 1.51M shares, EOLS reached a trading volume of 1495417 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Evolus Inc. [EOLS]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EOLS shares is $16.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EOLS stock is a recommendation set at 2.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Truist have made an estimate for Evolus Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on February 24, 2021. While these analysts kept the previous recommendation, Mizuho dropped their target price from $8 to $3. The new note on the price target was released on July 07, 2020, representing the official price target for Evolus Inc. stock.

The Average True Range (ATR) for Evolus Inc. is set at 1.45, with the Price to Sales ratio for EOLS stock in the period of the last 12 months amounting to 8.11. The Price to Book ratio for the last quarter was 13.48, with the Price to Cash per share for the same quarter was set at 3.44.

EOLS stock trade performance evaluation

Evolus Inc. [EOLS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 42.19. With this latest performance, EOLS shares gained by 107.40% in over the last four-week period, additionally plugging by 291.62% over the last 6 months – not to mention a rise of 63.59% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EOLS stock in for the last two-week period is set at 76.00, with the RSI for the last a single of trading hit 78.09, and the three-weeks RSI is set at 74.64 for Evolus Inc. [EOLS]. The present Moving Average for the last 50 days of trading for this stock 6.56, while it was recorded at 12.32 for the last single week of trading, and 4.63 for the last 200 days.

Evolus Inc. [EOLS]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Evolus Inc. [EOLS] shares currently have an operating margin of -271.40 and a Gross Margin at +65.22. Evolus Inc.’s Net Margin is presently recorded at -257.79.

Return on Total Capital for EOLS is now -68.37, given the latest momentum, and Return on Invested Capital for the company is -65.22. Return on Equity for this stock declined to -109.90, with Return on Assets sitting at -43.68. When it comes to the capital structure of this company, Evolus Inc. [EOLS] has a Total Debt to Total Equity ratio set at 121.51. Additionally, EOLS Total Debt to Total Capital is recorded at 54.85, with Total Debt to Total Assets ending up at 40.15. Long-Term Debt to Equity for the company is recorded at 120.00, with the Long-Term Debt to Total Capital now at 54.17.

Reflecting on the efficiency of the workforce at the company, Evolus Inc. [EOLS] managed to generate an average of -$383,123 per employee. Receivables Turnover for the company is 6.55 with a Total Asset Turnover recorded at a value of 0.17.Evolus Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.00 and a Current Ratio set at 10.40.

Earnings per share (EPS) analysis for Evolus Inc. [EOLS] stock

With the latest financial reports released by the company, Evolus Inc. posted -0.47/share EPS, while the average EPS was predicted by analysts to be reported at -0.73/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 35.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EOLS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Evolus Inc. go to 16.50%.

Evolus Inc. [EOLS]: Insider Ownership positions

There are presently around $98 million, or 24.10% of EOLS stock, in the hands of institutional investors. The top three institutional holders of EOLS stocks are: BLACKROCK INC. with ownership of 1,482,635, which is approximately -16.337% of the company’s market cap and around 3.60% of the total institutional ownership; SCHRODER INVESTMENT MANAGEMENT GROUP, holding 1,376,459 shares of the stock with an approximate value of $17.22 million in EOLS stocks shares; and VANGUARD GROUP INC, currently with $11.84 million in EOLS stock with ownership of nearly -0.921% of the company’s market capitalization.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Positions in Evolus Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 38 institutional holders increased their position in Evolus Inc. [NASDAQ:EOLS] by around 1,554,385 shares. Additionally, 42 investors decreased positions by around 1,053,913 shares, while 23 investors held positions by with 5,190,234 shares. The mentioned changes placed institutional holdings at 7,798,532 shares, according to the latest SEC report filing. EOLS stock had 19 new institutional investments in for a total of 741,402 shares, while 17 institutional investors sold positions of 413,963 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam